BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home » Topics » Science

Science
Science RSS Feed RSS

BioWorld MedTech’s Oncology Extra for Jan. 28, 2020

Jan. 28, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: SABR showing promise for spinal metastases; Chromosome amplification drives cancer progression via effects on secretion; IMRT shows well in study of upper-tract urothelial carcinoma
Read More
DNA testing illustration
Feisty old folks

Sprightly genomes bring insights into healthy aging, early-onset illness

Jan. 28, 2020
By John Fox
Australian researchers led by the Garvan Institute of Medical Research in Sydney have compiled the first reference genome database of healthy older Australians, which potentially can predict disease-linked gene variants more accurately than has been previously possible.
Read More
Eye and eye chart
Bringing glaucoma risk into focus

Multitrait analysis predicts glaucoma susceptibility, progression

Jan. 28, 2020
By John Fox
An international collaborative study led by geneticists at the Queensland Institute of Medical Research Berghofer Medical Research Institute (QIMR) in Brisbane, Australia, has used a multivariate approach to develop a polygenic risk score (PRS) for glaucoma.
Read More

BioWorld MedTech’s Cardiology Extra for Jan. 27, 2020

Jan. 27, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology.
Read More
T cells attacking cancer cell

Universal T-cell receptor could chase down multiple tumor types

Jan. 27, 2020
By Nuala Moran
LONDON – Researchers have discovered a T-cell receptor (TCR) that is both capable of targeting a range of solid tumors and independent of human leukocyte (HLA) type, opening up the prospect of developing a universal anticancer T-cell therapy.
Read More

BioWorld MedTech’s Neurology Extra for Jan. 24, 2020

Jan. 24, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Axomax Technologies
Read More
Eye and eye chart
Bringing glaucoma risk into focus

Multitrait analysis predicts glaucoma susceptibility, progression

Jan. 24, 2020
By John Fox
An international collaborative study led by geneticists at the Queensland Institute of Medical Research Berghofer Medical Research Institute (QIMR) in Brisbane, Australia, has used a multivariate approach to develop a polygenic risk score (PRS) for glaucoma.
Read More
Blue puzzle pieces, red ribbon

Bench Press for Jan. 24, 2020

Jan. 24, 2020
By Anette Breindl
Two independent groups of researchers have achieved HIV latency reversal not just in T cells in the bloodstream, but also in tissues, in animal models of HIV infection. Latently infected cells, which have nonreplicating HIV integrated into their genomes, are a major barrier to curing HIV, and attempts to reactivate latently infected cells, which would sensitize the virus in them to antiretroviral treatment, are one major area of HIV cure research.
Read More

BioWorld MedTech’s Diagnostics Extra for Jan. 23, 2020

Jan. 23, 2020
By Meg Bryant
Keeping you up to date on recent developments in diagnostics.
Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 22, 2020

Jan. 22, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Renovos Biologics
Read More
Previous 1 2 … 167 168 169 170 171 172 173 174 175 … 190 191 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 10, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing